In human cancer, PIK3CA mutations are detected in DCIS [5], [6], [7] suggesting that PIK3CA mutation is an early event in the tumorigenic process and that, presumably, other mutational events are required to initiate progression to invasive carcinoma. Here, PIK3CA is linked to invasive carcinoma.